1-8 of 8
Marco Frentsch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Flow Cytometric Analysis of Microbial Diversity in Patients with Aggressive Lymphoma Disease Undergoing Chemoimmunotherapy

Maren Schmiester, René Maier, René Riedel, Marco Frentsch, Robert R. Jenq, Christine B. Peterson, Liangliang Zhang, Lars Bullinger, Hyun-Dong Chang, Il-Kang Na
Journal: Blood
Blood (2021) 138 (Supplement 1): 4005.
https://doi.org/10.1182/blood-2021-146429
Published: 2021
Journal Articles

Single-Cell Clonal Tracking in Allogeneic Hematopoietic Stem Cell Transplantation Reveals Time Dependent and Distinct Functional Patterns in Traceable Donor T Cell Clones

Friedrich Wittenbecher, Luisa Keilholz, Benedikt Obermayer, Thomas Conrad, Marco Frentsch, Igor Wolfgang Blau, Lam Giang Vuong, Franziska Borchert, Stella Lesch, Kamran Movasshagi, Carola Tietze-Bürger, Olaf Penack, Johann Ahn, Dieter Beule, Lars Bullinger, Il-Kang Na
Journal: Blood
Blood (2021) 138 (Supplement 1): 335.
https://doi.org/10.1182/blood-2021-150093
Published: 2021
Journal Articles

CD40L + CD8 + T-Cell Dependent Antitumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Joanna Listopad, Regina Stark, Alberto Sada Japp, Nadine Matzmohr, Sarah Meier, Ichiro Taniuchi, MD PhD, Thomas Blankenstein, PhD
Journal: Blood
Blood (2014) 124 (21): 5818.
https://doi.org/10.1182/blood.V124.21.5818.5818
Published: 2014
Journal Articles

Inherent CD40L Expression Complements CD8 + T Cell Dependent Anti-Tumor Immunity

Andreas Thiel, PhD, Marco Frentsch, Regina Stark, Alberto Sada Japp, Joanna Listopad, Nadine Matzmohr, Sarah Meier, Dirk Busch, Axel Schulz, Thomas Blankenstein
Journal: Blood
Blood (2013) 122 (21): 4494.
https://doi.org/10.1182/blood.V122.21.4494.4494
Published: 2013
Journal Articles

CD40L expression permits CD8 + T cells to execute immunologic helper functions

Marco Frentsch, Regina Stark, Nadine Matzmohr, Sarah Meier, Sibel Durlanik, Axel R. Schulz, Ulrik Stervbo, Karsten Jürchott, Friedemann Gebhardt, Guido Heine, Morgan A. Reuter, Michael R. Betts, Dirk Busch, Andreas Thiel
Journal: Blood
Blood (2013) 122 (3): 405–412.
https://doi.org/10.1182/blood-2013-02-483586
Published: 2013
Includes: Supplemental data
Journal Articles

High Efficiency Isolation of Alloantigen-Reactive Foxp3 + Natural Regulatory T Cells According to Specific Activation Marker Signatures

Anne Schoenbrunn, Jacqueline Keye, Siegfried Kohler, Marco Frentsch, Beate Moewes, Alexander Scheffold, Chiara Romagnani, Andreas Thiel
Journal: Blood
Blood (2011) 118 (21): 1915.
https://doi.org/10.1182/blood.V118.21.1915.1915
Published: 2011
Journal Articles

Treatment of Adenovirus Infection by Adoptive Immunotherapy: Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific Cellular Immunity.

Olga Arbach, MD, Marco Frentsch, PhD, Barbara Chmielewicz, PhD, Marco Kaiser, PhD, Heinz Ellerbrock, PhD, Roland Lauster, PhD, Renate Arnold, MD, Andreas Radbruch, PhD, Sebastian Voigt, MD, Wolfram Ebell, MD, Andreas Thiel, PhD
Journal: Blood
Blood (2006) 108 (11): 2930.
https://doi.org/10.1182/blood.V108.11.2930.2930
Published: 2006
Journal Articles

Adenovirus Capsid Hexon Is the Main Target Protein of Adenovirus-Specific CD4 + T-Cells: Fundamentals for Targeting Adenovirus by Adoptive Immunotherapy.

Olga Arbach, MD, Marco Frentsch, Sebastian Voigt, MD, Barbara Chmielewicz, PhD, Marco Kaiser, Heins Ellerbrok, PhD, Roland Lauster, PhD, Andreas Radbruch, PhD, Alexander Scheffold, PhD, Wolfram Ebell, MD, Andreas Thiel, PhD
Journal: Blood
Blood (2005) 106 (11): 3034.
https://doi.org/10.1182/blood.V106.11.3034.3034
Published: 2005